AstraZeneca Pharma UK Ltd.Share price target 2025,2026 to 2030
AstraZeneca Pharma UK Ltd.Share price target:
Are you considering investing in Astrazeneca Pharma stock? Do you want to know the future share price forecast? The first step in investing is to analyze the stock. There are tons of tools and share charts available on the internet. But picking the right stock that aligns with your interest is a bit difficult. But that hustle is over.
Today, I am going to explain the AstraZeneca share price target for the years 2025, 2026, and 2030. Additionally, we will conduct some fundamental analysis of AstraZeneca to help you understand whether you invest or not.
Astrazeneca’s current stock details
| Open Price | 11,382 |
| Previous Close: | 11,248 |
| Volume | 1.39M |
| Shares out | 1,550.69M |
| Beta | 0.15 |
| Revanue | 56.5B |
| Market Capitalization | 175.41B |
| BOOK VALUE | 21.01 |
| ROE | 19.7% |
| Upper Circuit Limit: | 11,384 |
| Lower Circuit Limit | 11,288 |
| 52-Week High | 12,256 |
| 52-Week Low | 9,574 |
| Face Value | £0.25 |
| EPS | 5.3084 |
| DIVIDENT(yield) | 244.70(2.18%) |
| Revanue | 56.5B |
| EBITDA | 19.13B |
| Book Value Per Share: | 21.01 |
| P/E Ratio | 28.75 |
Astrazeneca Price Target Forecasts from 2025 to 2030
See more : Bellaway plc share price
The table below shows astrazeneca share price target for the coming years
| Year | Minimum Target | Maximum Target |
| 2025 | £130.00 | £140.00 |
| 2026 | £138.00 | £152.00 |
| 2027 | £146.00 | £165.00 |
| 2028 | £155.00 | £165.30 |
| 2029 | £165.00 | £200.00 |
| 2030 | £175.00 | £225.00 |
AstraZeneca Pharma share price target 2025
The share price of Astrazeneca is based on our analysis, latest market trends for 2025, the lowest price target for AstraZeneca is £130.00, while the highest is £140.00
AstraZeneca Pharma share price target 2026
The share price of Astrazeneca is variable, may go uptrend or a downtrend. According to our latest market forecast for 2026, the lowest price target for AstraZeneca is £138.00, while the highest is £152.00
AstraZeneca Pharma share price target 2027
The share price of Astrazeneca is probably go rise or a fall. According to our latest forecast for 2027, the lowest price target for AstraZeneca is , while the highest is £165.00
AstraZeneca Pharma share price target 2028
The share price of Astrazeneca is may or may not vary. According to our latest market forecast for 2028, the lowest price target for AstraZeneca is £155.00, while the highest is £165.30
AstraZeneca Pharma share price target 2029
The share price of Astrazeneca is variable, may go uptrend or a downtrend. According to our latest market forecast for 2029, the lowest price target for AstraZeneca is £165.00, while the highest is £200.00
AstraZeneca Pharma share price target 2030
In our analysis price of Astrazeneca is variable, may go uptrend or a downtrend. According to our latest market forecast for 2030, the lowest price target for AstraZeneca is £175.00 , while the highest is £225.00
AstraZeneca Pharma share profit calculator
Investment Calculator
About AstraZeneca Pharma uk
Founded in 1999 through the merger of Astra AB and Zeneca Group, AstraZeneca plc is headquartered in Cambridge, United Kingdom and operates as a global biopharmaceutical company. Listed on the London Stock Exchange (LSE) and NASDAQ Stockholm under the ticker AZN.
| Company Name | AstraZeneca plc |
| Sector | Healthcare |
| Industry | Pharmaceuticals, Biotechnology |
| IPO | 1999 |
| Listed Exchange | London Stock Exchange |
| CEO | Pascal Soriot |
AstraZeneca specializes in the discovery and commercialization of prescription medicines in oncology, cardiovascular, and respiratory diseases. Its strategic pivot towards biologics and precision medicines, along with expansion in emerging markets, positions it as a key player in the global pharmaceutical industry.
AstraZeneca Pharma revenue performance
| Financial metric | Amount |
| Revenue | $45.81 billion |
| Adjusted Profit Before Tax | $15.53 billion |
| Statutory Profit Before Tax | $6.90 billion |
| Debts | $24.33 billion |
| Free Cash Flow | $8.86 billion |
AstraZeneca Pharma share holding patterns
- Mutual Funds & ETFs – 46.07%
- Other Institutional Investors -38.92%
- Public Companies & Retail Investors – 15.01%
AstraZeneca Pharma competitors market cap
- Johnson & Johnson (JNJ) – £280 billion
- Novo Nordisk (NOVO B) – £515 billion
- GSK plc (GSK) – £65 billion
How to buy AstraZeneca Pharma share
To buy AstraZeneca (LSE: AZN) shares:
- Choose a stockbroker (like Hargreaves Lansdown, Freetrade, or your bank’s app).
- Open and fund your investment account.
- Search for the ticker symbol AZN.
- Place an order to buy the number of shares you want. The shares will then be in your portfolio.
conclusion
AstraZeneca is an absolute giant in the pharma world. Think of them as torch bearer medicines pharma research, especially in cancer treatment, where they are a top player. They’re constantly pouring money into R&D to find the next big thing, and their pipeline of new drugs looks really strong.
Because they’re so huge and have drugs that millions of people need ,helps to cure, it’s a pretty reliable, defensive stock. It’s not going to down overnight, but history shows that but it’s a solid, steady performer, despite facing multiple clinical trail fails.
The current AstraZeneca share price target shows this. It suggests, our analysts see continued, steady growth ahead, driven by their successful new medicines. It’s the kind of stock you buy and hold for the long run, not one you trade for a quick win.
FAQ
What is the AstraZeneca Pharma Share Price prediction in 2025?
AstraZeneca Pharma Share Price Target 2025 is between Rs £130.00 and Rs £152.00.
What is the AstraZeneca Pharma Share Price Target 2026?
AstraZeneca Pharma Share Price Target for the year 2026 is between £138.00 and £152.00.
What is the AstraZeneca Pharma Share Price Prediction 2030?
AstraZeneca Pharma Share Price Prediction 2030 is predicted to remain between £175.00 and £225.00.
What is the AstraZeneca Pharma Share Price Target 2045?
AstraZeneca Pharma Share Price Target 2040 is between £330.00 and £600.00.
What is the 52-week high and low of Astrazeneca?
Is Astrazeneca a good stock to invest in?
Whether AstraZeneca is a good investment depends on your goals.
Yes, it is a good investment for long-term growth and stability. It is a market leader with a powerful pipeline of new drugs (especially in cancer) and a reliable dividend, making it a strong, defensive holding.
No, it may not be a good investment if you fear risk. The stock trades at a high valuation, and its success is always vulnerable to clinical trial failures or patent expirations, which are inherent risks in the pharmaceutical industry.
Does Astrazeneca give dividends?
Yes, AstraZeneca plc (LSE: AZN) pays a dividend and is a well-established dividend-paying company.
What are the risks of investing in Astrazeneca?
Here are the key risks of investing in AstraZeneca in a short,
- Patent Expiry: When patents on its blockbuster drugs expire, cheaper generic versions can cause a sharp drop in sales and profits.
- Clinical Trial Failure: Drug development is expensive and risky. A promising drug failing in late-stage trials can wipe out billions in investment and future revenue.
- High Valuation: The stock often trades at a premium price. If growth slows, its share price could fall more sharply than cheaper stocks.
- Regulatory Pressure: Governments worldwide are constantly trying to lower drug prices, which could squeeze future profitability.